Deals Of The Week: Pfizer Leads The Action Even After Wyeth Purchase
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
Vertex Braces For HCV Combo Paradigm With ViroChem Buyout
Takeover gives Vertex two clinical-stage polymerase inhibitors, and recalls Gilead’s key Triangle grab.
Pfizer, Bausch & Lomb Team Up On Ophthalmology
U.S. co-promotion will combine sales forces to promote Pfizer’s Xalatan and Bausch & Lomb’s Alrex, Lotemex, Zylet and besifloxacin.
Pfizer Bulks Up Its Generics Business
Deal with the Indian pharma company Aurobindo highlights the giant’s interest in expanding its product mix.